ArticleCureus2025
Multiple Eruptive Dermatofibromas: A Case Series and Review of Diagnostic Challenges and Systemic Associations.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Multiple eruptive dermatofibromas (MEDF) is a rare dermatological condition characterized by the sudden appearance of multiple benign skin lesions, often associated with systemic or autoimmune conditions. This case series describes three female patients with MEDF, highlighting their distinct clinical features and systemic associations. Diagnoses were confirmed through consistent histopathological findings, demonstrating the importance of integrating clinical, dermoscopic, and histopathological evaluations in diagnosing MEDF. The differential diagnosis included other dermatological conditions with overlapping features, which were excluded based on clinical and pathological findings. This report emphasizes the potential role of immune dysregulation and genetic predisposition in MEDF pathogenesis. It underscores the need for further research to understand its mechanisms better, improve diagnostic accuracy, and establish standardized management approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.